4.3 Article

Risk Factors for Legal Blindness in 77 Japanese Patients with Endogenous Endophthalmitis: A Multicenter Cohort Study from J-CREST

期刊

OCULAR IMMUNOLOGY AND INFLAMMATION
卷 31, 期 7, 页码 1505-1512

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/09273948.2022.2112237

关键词

Endogenous endophthalmitis; Endophthalmitis; pressure injuries; retrospective study; vitrectomy

向作者/读者索取更多资源

This retrospective observational study investigated potential predictive factors for visual prognosis in Japanese patients with endogenous endophthalmitis. The study found that pressure injuries, severe clinical symptoms, pathogen identification, and poor baseline visual acuity were risk factors for visual impairment at 12 weeks after treatment initiation. Staphylococcus aureus and fungus were associated with a better visual impairment outcome.
Purpose We investigated potential predictive factors for visual prognosis in Japanese patients with endogenous endophthalmitis. Design Retrospective observational multicenter cohort study. Methods We examined the characteristics of 77 Japanese patients with endogenous endophthalmitis and performed statistical analyses of these real-world data. The primary endpoint was the identification of factors associated with visual prognosis. We examined differences between patients in the better vision and legal blindness groups at 12 weeks after treatment initiation. Results The five risk factors for visual impairment at 12 weeks after treatment initiation were presence of pressure injuries, severe clinical symptoms (presence of eye pain and ciliary injection), pathogen identification, and poor best-corrected visual acuity at baseline. Staphylococcus aureus and fungus were associated with a better visual impairment outcome. Conclusions Endogenous endophthalmitis remains a severe ocular infection; however, it can be managed with rapid treatments, as well as other advances in medical knowledge and technology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据